Cargando…

A novel approach for characterizing variations in serum peptides in rheumatic heart disease

BACKGROUND & OBJECTIVES: Acute rheumatic fever and rheumatic heart disease (RHD) are important public health problems in developing countries. In this study, peptidomic analyses on RHD patients and healthy individuals were performed to characterize variations in serum peptide levels using label-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaochen, Yue, Qin, Jia, Weikun, Zhang, Jinbao, Ouyang, Hui, Xin, Dong, Xiao, Yingbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555066/
https://www.ncbi.nlm.nih.gov/pubmed/28749400
http://dx.doi.org/10.4103/ijmr.IJMR_1581_14
_version_ 1783256881260658688
author Wu, Xiaochen
Yue, Qin
Jia, Weikun
Zhang, Jinbao
Ouyang, Hui
Xin, Dong
Xiao, Yingbin
author_facet Wu, Xiaochen
Yue, Qin
Jia, Weikun
Zhang, Jinbao
Ouyang, Hui
Xin, Dong
Xiao, Yingbin
author_sort Wu, Xiaochen
collection PubMed
description BACKGROUND & OBJECTIVES: Acute rheumatic fever and rheumatic heart disease (RHD) are important public health problems in developing countries. In this study, peptidomic analyses on RHD patients and healthy individuals were performed to characterize variations in serum peptide levels using label-free quantitation approaches. METHODS: Blood samples were obtained from 160 healthy controls and 160 RHD patients. Of the 448 identified peptides, 272 were analyzed by two label-free mass spectrometry methods, the spectral count and spectral index. RESULTS: There were 38 proteins and 95 peptides with significant (adjusted P<0.001) differences in the abundance of peptides between healthy controls and RHD patients, including multiple peptides derived from histone H2B, villin-like protein, complement C4-B and motile sperm domain containing protein-2. The levels of 10 peptides were upregulated, and 85 peptides were downregulated in patients compared to controls. In addition, in patients, the levels of four proteins were upregulated and 34 were downregulated compared to controls. INTERPRETATION & CONCLUSIONS: This study shows that detection of significant changes in serum peptides reflects the difference between RHD patients and healthy controls. This label-free method may be helpful for clinicians to treat RHD patients during the perioperative period.
format Online
Article
Text
id pubmed-5555066
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55550662017-08-30 A novel approach for characterizing variations in serum peptides in rheumatic heart disease Wu, Xiaochen Yue, Qin Jia, Weikun Zhang, Jinbao Ouyang, Hui Xin, Dong Xiao, Yingbin Indian J Med Res Original Articles BACKGROUND & OBJECTIVES: Acute rheumatic fever and rheumatic heart disease (RHD) are important public health problems in developing countries. In this study, peptidomic analyses on RHD patients and healthy individuals were performed to characterize variations in serum peptide levels using label-free quantitation approaches. METHODS: Blood samples were obtained from 160 healthy controls and 160 RHD patients. Of the 448 identified peptides, 272 were analyzed by two label-free mass spectrometry methods, the spectral count and spectral index. RESULTS: There were 38 proteins and 95 peptides with significant (adjusted P<0.001) differences in the abundance of peptides between healthy controls and RHD patients, including multiple peptides derived from histone H2B, villin-like protein, complement C4-B and motile sperm domain containing protein-2. The levels of 10 peptides were upregulated, and 85 peptides were downregulated in patients compared to controls. In addition, in patients, the levels of four proteins were upregulated and 34 were downregulated compared to controls. INTERPRETATION & CONCLUSIONS: This study shows that detection of significant changes in serum peptides reflects the difference between RHD patients and healthy controls. This label-free method may be helpful for clinicians to treat RHD patients during the perioperative period. Medknow Publications & Media Pvt Ltd 2017-03 /pmc/articles/PMC5555066/ /pubmed/28749400 http://dx.doi.org/10.4103/ijmr.IJMR_1581_14 Text en Copyright: © 2017 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Articles
Wu, Xiaochen
Yue, Qin
Jia, Weikun
Zhang, Jinbao
Ouyang, Hui
Xin, Dong
Xiao, Yingbin
A novel approach for characterizing variations in serum peptides in rheumatic heart disease
title A novel approach for characterizing variations in serum peptides in rheumatic heart disease
title_full A novel approach for characterizing variations in serum peptides in rheumatic heart disease
title_fullStr A novel approach for characterizing variations in serum peptides in rheumatic heart disease
title_full_unstemmed A novel approach for characterizing variations in serum peptides in rheumatic heart disease
title_short A novel approach for characterizing variations in serum peptides in rheumatic heart disease
title_sort novel approach for characterizing variations in serum peptides in rheumatic heart disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555066/
https://www.ncbi.nlm.nih.gov/pubmed/28749400
http://dx.doi.org/10.4103/ijmr.IJMR_1581_14
work_keys_str_mv AT wuxiaochen anovelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT yueqin anovelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT jiaweikun anovelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT zhangjinbao anovelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT ouyanghui anovelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT xindong anovelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT xiaoyingbin anovelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT wuxiaochen novelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT yueqin novelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT jiaweikun novelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT zhangjinbao novelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT ouyanghui novelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT xindong novelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease
AT xiaoyingbin novelapproachforcharacterizingvariationsinserumpeptidesinrheumaticheartdisease